The effect of Silymarin in type 2 diabetes.
Phase 2
Completed
- Conditions
- Type 2 Diabetic.Chapter IV Endocrine, nutritional and metabolic diseases(E00-E90)I Certain
- Registration Number
- IRCT20230318057749N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with type 2 diabetes referring to the clinic of the Endocrine Research Institute of Iran University of Medical Sciences
Age group 30-68 years
Fasting plasma sugar more than 126 mg/dl
Duration of the onset of the disease more than 2 years
Exclusion Criteria
Pregnant and lactating women
People less than 30 years old
Following a special diet
Suffering from cardiovascular disease, infectious diseases, kidney disease, thyroid disease
Treatment with Sealy Marine in 30 days before the study
Using chemical drugs and herbal supplements and nutritional supplements
Insulin therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid profile and Glycemic index. Timepoint: Measurement of lipid profile and glycemic index at the beginning of the study and after consumption of silymarin study. Method of measurement: laboratory kit.
- Secondary Outcome Measures
Name Time Method